secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001193125-25-142359
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio appoints Cindy Driscoll as Principal Financial Officer; Emily Pimblett resigns
--------------------------------------------------------------------------------

- Appointed Cindy Driscoll as SVP Finance, principal financial officer and principal accounting officer effective June 17, 2025.
- Driscoll receives $355k base salary, 35% target bonus, and 200,000-share stock option under 2025 Inducement Plan.
- Emily Pimblett resigns as SVP Finance and Chief Accounting Officer, effective June 30, 2025.
- CEO Aoife Brennan ceases interim principal financial officer role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525142359/0001193125-25-142359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525142359/d939351d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer